A detailed history of Geode Capital Management, LLC transactions in A Ikido Pharma Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 43,369 shares of AIKI stock, worth $164,802. This represents 0.0% of its overall portfolio holdings.

Number of Shares
43,369
Previous 46,111 5.95%
Holding current value
$164,802
Previous $175,000 6.29%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
N/A
-2,742 Reduced 5.95%
43,369 $164,000
Q2 2024

Aug 09, 2024

BUY
N/A
6,882 Added 17.54%
46,111 $175,000
Q3 2023

Nov 13, 2023

SELL
N/A
-4,082 Reduced 9.42%
39,229 $149,000
Q4 2022

Feb 13, 2023

SELL
$3.07 - $7.21 $300 - $706
-98 Reduced 0.23%
43,311 $140,000
Q3 2022

Nov 14, 2022

BUY
$5.6 - $7.03 $1,730 - $2,172
309 Added 0.72%
43,409 $296,000
Q2 2022

Aug 12, 2022

BUY
$4.59 - $7.99 $197,829 - $344,369
43,100 New
43,100 $253,000

Others Institutions Holding AIKI

About AIkido Pharma Inc.


  • Ticker AIKI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 5,485,100
  • Market Cap $20.8M
  • Description
  • AIkido Pharma Inc., a biotechnology company, focuses on developing small-molecule anti-cancer therapeutics. The company's pipeline of therapeutics includes therapies for prostate cancer, pancreatic cancer, acute myeloid leukemia (AML), and acute lymphoblastic leukemia. It is developing DHA-dFdC, a pancreatic drug candidate; and KPC34, a small mo...
More about AIKI
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.